- Home
- CRNX vs RSI Comparison
CRNX vs RSI Comparison
Compare CRNX & RSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNX | RSI |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.6B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CRNX | RSI |
|---|---|---|
| Price | $83.73 | $31.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $76.75 | $28.20 |
| AVG Volume (30 Days) | ★ 6.8M | 2.4M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 933.33 |
| EPS | N/A | ★ 0.08 |
| Revenue | $1,039,000.00 | ★ $1,134,428,000.00 |
| Revenue This Year | $720.10 | $25.44 |
| Revenue Next Year | $184.67 | $14.27 |
| P/E Ratio | ★ N/A | $391.50 |
| Revenue Growth | N/A | ★ 22.76 |
| 52 Week Low | $25.83 | $15.18 |
| 52 Week High | $84.00 | $34.53 |
Technical Indicators
Market Signals| Indicator | CRNX | RSI |
|---|---|---|
| Relative Strength Index (RSI) | 92.07 | 49.12 |
| Support Level | $33.50 | $25.56 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.18 | 1.24 |
| MACD | -0.10 | -0.38 |
| Stochastic Oscillator | 53.51 | 17.08 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.